Intercept Pharma Stock Price (NASDAQ:ICPT)

Add to My Stocks
$59.13 $1.65 (2.71%) ICPT stock closing price Feb 21, 2018 (Closing)
Prev Close* : $60.78
Market Cap:
$1.53B
Day Low: $59.03
52 Week Low: $51.05
Open: $61
Volume: -
Day High: $61.85
52 Week High: $135.59
Dividend:
0.00

Latest Stock Market News

Latest Articles

Intercept Pharma News - From Partners

ICPT Stockcharts

View ICPT PE ratio, PS ratio stocks charts and compare with peers.
ICPT Chart
Note: Compare Intercept Pharma stock price history with the index and industry peers.

Intercept Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
11.36
PB ratio (
price to book ratio
)
-999.0000

Intercept Pharma Returns

ROE
(return on equity)
-172%

Intercept Pharma Financial Ratios

Asset Turnover
-
Receivables Turnover
-
Debt to Equity
-
Dividend Yield
0%

ICPT Industry Peers

Company Price Change (%)
Iovance Biothpt (IOVA)17.750.6 (3.5%)
Repligen (RGEN)32.40.64 (2.02%)
Conatus Pharma (CNAT)5.160.22 (4.09%)
Fibrogen (FGEN)561.4 (2.56%)
Galmed Pharma (GLMD)5.620.29 (5.44%)
Medicinova (MNOV)10.610.4 (3.63%)
Viking Therapeutics (VKTX)6.820.38 (5.9%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Fate Therapeutics (FATE)10.591.42 (15.49%)
NeoGenomics (NEO)8.080.72 (9.78%)
Sunesis Pharma (SNSS)6.990.62 (9.73%)
Compugen (CGEN)3.250.2 (6.56%)
Fortress Biotech (FBIO)3.630.21 (6.14%)
Alder BioPharma (ALDR)14.550.7 (5.05%)
Stemline Therapeutics (STML)16.550.75 (4.75%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018
CompanyPriceChange (%)
GTx (GTXI)15.461.25 (7.48%)
Catalyst Biosciences (CBIO)27.541.96 (6.64%)
Five Prime Therapeutics (FPRX)17.681.21 (6.41%)
Arbutus Biopharma (ABUS)5.250.25 (4.55%)
Ultragenyx Pharma (RARE)46.311.87 (3.88%)
MediciNova (MNOV)10.610.4 (3.63%)
The Medicines Company (MDCO)31.621.18 (3.6%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018

Intercept Pharmaceuticals Inc Stock News - Partner Headlines

Intercept Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues24.95M2.78M1.74M1.62M2.44M
Net Income-412.83M-226.42M-283.22M-67.79M-43.64M
Total Operating Expense427.48M231.93M114.91M41.07M21.35M
View Intercept Pharma income statement
balance sheet20162015201420132012
Total Assets739.25M655.75M254.14M150.31M112.17M
Total Liabilities424.32M53.6M23.25M67.91M46.26M
Shareholders Equity314.93M602.14M230.89M82.4M65.91M
View Intercept Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities8.43M21.34M---0.59M
Net Cash from (used by) Operating Activities-342.44M-162.9M-87.73M-28M-15.74M
Increase (Decrease) in Prop Plant And Equipment-5.07M-5.93M-4.64M-1.62M-0.03M
View Intercept Pharma cash flow statement

Intercept Pharma Stock Message Board

Intercept Pharma stock price ended the last trading day at $59.13. Intercept Pharma market capitalization is $1.53B and it represents the total market value of ICPT stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Intercept Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Intercept Pharma is worth a lot, it will most likely be reflected in an inflated Intercept Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 672,031 shares were traded with a closing stock price of $59.13 as of Feb 21, 2018, as can be seen from Intercept Pharma stock quote. One can view Intercept Pharma stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Intercept Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of ICPT, view Intercept Pharma stock price history.